| Acne |
No |
| Active Half-Life |
10 hours |
| Active substance |
Liothyronine Sodium |
| Also known as |
Cytosine arabinoside |
| Aromatization |
No |
| Blood pressure |
Can cause hypotension |
| Chemical name |
4-Amino-1-ОІ-D-arabinofuranosyl-2(1H)-pyrimidinone |
| Classification |
Thyroid hormone |
| Dosage |
25-100mcg/day |
| Dosage (medical) |
Varies with condition, commonly 100 mg/mВІ/day intravenously in leukemia |
| Dosage (sports) |
Not applicable |
| Effects |
Reduces cancer cell proliferation |
| Formula |
C9H13N3O5 |
| Half-life |
10 minutes (intravenous), around 2 hours (after deamination) |
| HBR |
No |
| Hepatotoxicity |
No |
| Lab Test |
CBC (Complete Blood Count) and liver function tests |
| Main action |
Inhibits DNA synthesis |
| Raw Material |
Liothyronine Sodium |
| Side effects |
Nausea, vomiting, diarrhea, liver dysfunction, bone marrow suppression |
| Storage conditions |
Store at 20В°C to 25В°C (68В°F to 77В°F) |
| Substance class |
Antimetabolite, specifically a nucleoside metabolic inhibitor |
| Trade name |
Cytosar-U, Ara-C |
| Use in sports |
None |
| Water Retention |
No |
| Manufacturer |
Sixpex |
| Packing |
100 tabs (25 mcg/tab) |
